missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Nimotuzumab Recombinant Human Monoclonal Antibody (h-R3 (Nimotuzumab)), Invitrogen™
Human Recombinant Monoclonal Antibody
Marca: Invitrogen MA548049
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Specificity: Binds to human EGFR domain III.
Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor (EGFR).
Especificaciones
| Nimotuzumab | |
| Recombinant Monoclonal | |
| 1 mg/mL | |
| PBS with 0.02% ProClin 300 | |
| Human | |
| Affinity chromatography | |
| RUO | |
| Human | |
| Liquid |
| Flow Cytometry, Immunohistochemistry, Inhibition Assays | |
| h-R3 (Nimotuzumab) | |
| Unconjugated | |
| hR3; Theraloc | |
| This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors. | |
| 200 μg | |
| Primary | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| IgG1 κ |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Nimotuzumab Recombinant Human Monoclonal Antibody (h-R3 (Nimotuzumab)), Invitrogen™ > 200 μg; Unconjugated
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido
